Scarica l'app Stockscreener
13.35
4.15%
-0.5659
Precedente Chiudi:
$13.92
Aprire:
$13.73
Volume 24 ore:
993.57K
Relative Volume:
0.45
Capitalizzazione di mercato:
$3.81B
Reddito:
$1.16B
Utile/perdita netta:
$77.95M
Rapporto P/E:
49.26
EPS:
0.2711
Flusso di cassa netto:
$144.80M
1 W Prestazione:
-11.40%
1M Prestazione:
-21.38%
6M Prestazione:
-16.87%
1 anno Prestazione:
+18.29%
Intervallo 1D:
$13.32
$13.85
Intervallo di 1 settimana:
$13.32
$15.05
Portata 52W:
$9.53
$19.85
Sotera Health Co Stock (SHC) Company Profile
Nome
Sotera Health Co
Settore
Industria
Telefono
440-262-1410
Indirizzo
9100 SOUTH HILLS BLVD, SUITE 300, BROADVIEW HEIGHTS
Compare SHC vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SHC
Sotera Health Co
|
13.39 | 3.96B | 1.16B | 77.95M | 144.80M | 0.2711 |
|
TMO
Thermo Fisher Scientific Inc
|
476.98 | 184.15B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
189.24 | 137.93B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
579.00 | 47.82B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
112.15 | 32.62B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
289.14 | 29.19B | 3.17B | 642.63M | 516.49M | 10.77 |
Sotera Health Co Stock (SHC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-09 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2026-01-09 | Ripresa | RBC Capital Mkts | Outperform |
| 2025-12-18 | Iniziato | William Blair | Outperform |
| 2025-11-13 | Iniziato | BMO Capital Markets | Outperform |
| 2025-05-05 | Aggiornamento | Goldman | Neutral → Buy |
| 2024-12-06 | Iniziato | Goldman | Neutral |
| 2024-05-21 | Iniziato | Piper Sandler | Neutral |
| 2024-04-03 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-03-25 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-02-06 | Ripresa | KeyBanc Capital Markets | Sector Weight |
| 2023-06-26 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-23 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2023-01-11 | Aggiornamento | Barclays | Underweight → Overweight |
| 2023-01-11 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2022-11-15 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-10-05 | Downgrade | Citigroup | Buy → Neutral |
| 2022-09-26 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2022-09-21 | Downgrade | JP Morgan | Overweight → Underweight |
| 2022-09-20 | Downgrade | Goldman | Buy → Neutral |
| 2022-06-09 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2022-04-06 | Iniziato | Wolfe Research | Outperform |
| 2022-03-03 | Downgrade | Jefferies | Buy → Hold |
| 2022-03-02 | Downgrade | Barclays | Overweight → Equal Weight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2021-01-14 | Iniziato | Robert W. Baird | Outperform |
| 2020-12-15 | Iniziato | Citigroup | Buy |
| 2020-12-15 | Iniziato | Credit Suisse | Outperform |
| 2020-12-15 | Iniziato | Goldman | Buy |
| 2020-12-15 | Iniziato | JP Morgan | Overweight |
| 2020-12-15 | Iniziato | Jefferies | Buy |
| 2020-12-15 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-12-15 | Iniziato | RBC Capital Mkts | Outperform |
Mostra tutto
Sotera Health Co Borsa (SHC) Ultime notizie
Sotera Health at Barclays Conference: Strategic Growth and Legal Challenges - Investing.com
Sotera Health Board Member Trades $229.05M In Company Stock - Benzinga
Insider Transaction: WARBURG PINCUS CO Sells $229.05M Worth Of Sotera Health Shares - Benzinga
Sotera Health Company (NASDAQ:SHC) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Sotera Health stockholders sell 25 million shares in secondary offering - Investing.com India
Sotera Health stockholders sell 25 million shares in secondary offering By Investing.com - Investing.com Canada
Sotera Health Ownership Shift As 25m Share Sale Tests Valuation - simplywall.st
Sotera Health (NASDAQ:SHC) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Wells Fargo Manages Offering for SHC - GuruFocus
Sotera Health shares fall 4.2% as private equity firms launch secondary offering By Investing.com - Investing.com South Africa
Sotera Health shares fall 4.2% as private equity firms launch secondary offering - Investing.com
Sotera Health Up 30% This Past Year, so Why Did One Fund Sell $4 Million in Shares? - AOL.com
Sotera Health (SHC) Launches 25 Million Share Secondary Offering - GuruFocus
Form 424B7 Sotera Health Co - StreetInsider
Warburg Pincus and GTCR affiliates to sell 25M Sotera Health shares - Stock Titan
SHC SEC FilingsSotera Health Co 10-K, 10-Q, 8-K Forms - Stock Titan
Sotera Health Company (SHC) Stock Analysis: Exploring a 30% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Sotera Health (SHC) Loses 13% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Finviz
Assessing Sotera Health (SHC) Valuation After Strong 2025 Results And 2026 Growth Guidance - simplywall.st
Sotera Health (SHC) Is Down 7.1% After Issuing 2026 Revenue Guidance And Marking 20th Growth Year - simplywall.st
SHC Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
SHC Should I Buy - Intellectia AI
Panel: Investors Failed To Show Sterilization Facility Owner Committed Fraud - Law360
FRAUD AND MANIPULATION—6th Cir.: Sterigenics class action dismissal affirmed by the Sixth Circuit - VitalLaw.com
Sotera Health wins appeal of investor lawsuit - Crain's Cleveland
Sotera Health is Now Oversold (SHC) - Nasdaq
Sotera Prevails in Investor Appeal of Emissions Disclosures Suit - Bloomberg Law News
Sotera Health: Strengthening Fundamentals, Margin Expansion, and Deleveraging Support Buy Rating and $20 Target - TipRanks
Sotera Health Company (NASDAQ:SHC) Q4 2025 Earnings Call Transcript - Insider Monkey
Sotera Health Company (SHC) Stock Analysis: A 16.85% Potential Upside In Healthcare Diagnostics - DirectorsTalk Interviews
Decoding Sotera Health Co (SHC): A Strategic SWOT Insight - GuruFocus
6th Circ. Affirms Dismissal Of Sotera Toxic Gas Investor Suit - Law360
Sotera Health Q4 2025 slides: 20th year of growth, margins hit 51% - Investing.com Australia
SHC: Citigroup Maintains "Buy" Rating, Raises Price Target to $2 - GuruFocus
Sotera Health (SHC) Margin Expansion To 6.7% Tests Premium 60.9x P/E Narrative - simplywall.st
Sotera Health Co (SHC) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges - GuruFocus
SHC Reports Strong Q4 Revenue, Exceeds Expectations - GuruFocus
SHC's Strong Q4 Revenue Surpasses Expectations with Robust Growt - GuruFocus
Sotera Health reports Q4 adjusted EPS 26c, consensus 24c - TipRanks
Sotera Health Q4 2025 slides: 20th year of growth, margins hit 51% By Investing.com - Investing.com South Africa
Sotera Health earnings beat by $0.02, revenue topped estimates - Investing.com Nigeria
Sotera Health Co reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Sotera Health beats Q4 2025 EPS forecasts By Investing.com - Investing.com Canada
Earnings call transcript: Sotera Health beats Q4 2025 EPS forecasts - Investing.com
Sotera Health General Counsel Alex Dimitrief to transition to outside advisor - TipRanks
Sotera Health (NASDAQ:SHC) Issues Quarterly Earnings Results - MarketBeat
Sotera Health (SHC) Announces Leadership Transition in Legal Dep - GuruFocus
SHC Projects Revenue and Earnings Growth for the Year - GuruFocus
Sotera Health Company's (NASDAQ:SHC) Q4 CY2025: Beats On Revenue - Finviz
Sotera Health (NASDAQ:SHC) Issues FY 2026 Earnings Guidance - MarketBeat
Stronger 2025 lifts Sotera Health (NASDAQ: SHC) guidance for 2026 - Stock Titan
Sotera Health Co Azioni (SHC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Sotera Health Co Azioni (SHC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| WARBURG PINCUS & CO. | Director |
Mar 06 '26 |
Sale |
15.27 |
15,000,000 |
229,050,000 |
19,102,952 |
| GTCR INVESTMENT XI LLC | Director |
Mar 06 '26 |
Sale |
15.27 |
10,000,000 |
152,700,000 |
12,735,301 |
| Petras Michael B. Jr. | Chairman & CEO |
Dec 08 '25 |
Sale |
16.45 |
434,104 |
7,141,011 |
0 |
| Petras Michael B. Jr. | Chairman & CEO |
Dec 08 '25 |
Sale |
16.45 |
315,896 |
5,196,489 |
552,790 |
0.51%
0.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):